• Subscribe
  • Webinars
  • White Papers
  • Buyer's Guide
  • PhotonicsNXT
  • Get Published!
    • Recent Quotes
    My Watchlist
    Indicators
    BioOptics Stock Watch
    Markets
    Stocks
    ETFs
    Tools
    Markets:
    Overview
    News
    Currencies
    International
    Treasuries
    Business Exposures
    < Previous 1 2 3 4 5 6 7 8 9
    ...
    99 100 Next >
    News headline image
    MDLN Investigation: Kessler Topaz Meltzer & Check, LLP Encourages Medline Inc. (NASDAQ: MDLN) Investors to Contact the Firm
    Via NewMediaWire
    Tickers MDLN
    Exposures Product Safety
    News headline image
    Aquestive Prepares FDA Resubmission for Severe Allergy Treatment Following Successful Study ↗
    Via Benzinga
    Exposures Product Safety
    News headline image
    Capricor Therapeutics, Inc. Notice of September 28, 2026 Application Deadline for Class Action Lawsuit - Contact Lewis Kahn, Esq. at Kahn Swick & Foti, LLC, Before Application Deadline
    Via Newsfile
    Topics Lawsuit
    Tickers CAPR SAP
    Exposures Financial Legal Product Safety
    News headline image
    FDA Panel Schedules to Evaluate GRAIL Premarket Approval Application for Multi-Cancer Early Detection Test ↗
    Via Benzinga
    Exposures Product Safety
    Entera Bio (NASDAQ:ENTX) Slides on Wider Q2 Loss Despite FDA Phase 3 Alignment and $275M Cash Raise ↗
    Via Chartmill
    Tickers ENTX
    Exposures Product Safety
    News headline image
    Nicolet Law Files First Lawsuit in the Nation Over Salmonella Javiana Outbreak Linked to Contaminated Jalapeños
    Via Law Firm Newswire
    Topics Economy Lawsuit Product Recall
    Exposures Financial Legal Product Safety
    News headline image
    Scholar Rock Overcomes Manufacturing Hurdle to Keep Lead Drug FDA Review on Schedule ↗
    Via Benzinga
    Exposures Product Safety
    News headline image
    NRx Pharmaceuticals Nears FDA Decision on Preservative-Free Ketamine After Review Clears Hurdles ↗
    Via MarketBeat
    Tickers NRXP
    Exposures Product Safety
    News headline image
    Ulcerative Colitis Market: Size, Trends, and Strategic Outlook 2026-2033 ↗
    Via Talk Markets
    Topics Economy
    Exposures Product Safety Supply Chain
    InvestorNewsBreaks – Quantum BioPharma Ltd. (NASDAQ: QNTM) (CSE: QNTM) Receives FDA Clearance to Advance Lucid-MS into Phase 2
    Via Investor Brand Network
    Tickers CSE:QNTM QNTM
    Exposures Product Safety
    BioMedNewsBreaks – Tonix Pharmaceuticals Holding Corp. (NASDAQ: TNXP) Reports Q2 Revenue of $13.5 Million as TONMYA Sales Reach $11 Million
    Via Investor Brand Network
    Tickers TNXP
    Exposures Product Safety
    NetworkNewsBreaks – Tonix Pharmaceuticals Holding Corp. (NASDAQ: TNXP) Reports Q2 Revenue of $13.5 Million as TONMYA Sales Reach $11 Million
    Via Investor Brand Network
    Tickers TNXP
    Exposures Product Safety
    News headline image
    Envoy Medical Reports Second Quarter 2026 Results and Achieves Key Regulatory and Clinical Milestones
    Via Newsfile
    Topics Intellectual Property
    Tickers ASX:COH COCH
    Exposures Intellectual Property Product Safety
    News headline image
    Hims & Hers Health Likely To Report Q2 Loss; These Most Accurate Analysts Revise Forecasts Ahead Of Earnings Call ↗
    Via Benzinga
    Exposures Product Safety
    News headline image
    EXCLUSIVE: Quantum BioPharma Achieves Major Milestone With FDA Clearance for Multiple Sclerosis Trial ↗
    Via Benzinga
    Exposures Product Safety
    News headline image
    Future Outlook of the Ovarian Cancer Drugs Market: Size, Trends & Growth ↗
    Via Talk Markets
    Topics Artificial Intelligence
    Exposures Artificial Intelligence Product Safety
    News headline image
    Global Precision Medicine Market: Size, Trends, Drivers, and Forecast 2026-2033 ↗
    Via Talk Markets
    Topics Artificial Intelligence
    Tickers PFE
    Exposures Artificial Intelligence Product Safety
    News headline image
    Can Turning Point Brands Defend a "Dr. Pepper"‑Size Share After the FDA's Nicotine Pouch Decision? ↗
    Via The Motley Fool
    Tickers KDP PM TPB
    Exposures Product Safety
    News headline image
    MDLN Investigation Notice: Kessler Topaz Meltzer & Check, LLP Encourages Medline Inc. (NASDAQ: MDLN) Investors to Contact the Firm
    Via NewMediaWire
    Tickers MDLN
    Exposures Product Safety
    News headline image
    Teleflex Q2 Earnings Call Highlights ↗
    Via MarketBeat
    Topics Earnings
    Tickers TFX
    Exposures Financial Product Safety
    News headline image
    MDLN Investigation: Kessler Topaz Meltzer & Check, LLP Encourages Medline Inc. (NASDAQ: MDLN) Investors to Contact the Firm
    Via NewMediaWire
    Tickers MDLN
    Exposures Product Safety
    News headline image
    Takeda (TAK) Q1 2026 Earnings Call Transcript ↗
    Via The Motley Fool
    Topics Earnings
    Tickers TAK
    Exposures Financial Product Safety
    News headline image
    Glaukos (GKOS) Q2 2026 Earnings Call Transcript ↗
    Via The Motley Fool
    Topics Earnings
    Tickers GKOS
    Exposures Financial Product Safety
    News headline image
    uniQure (QURE) Q2 2026 Earnings Call Transcript ↗
    Via The Motley Fool
    Topics Earnings
    Tickers QURE
    Exposures Financial Product Safety
    News headline image
    Boston Scientific (BSX) Q2 2026 Earnings Call Transcript ↗
    Via The Motley Fool
    Topics Earnings
    Tickers BSX
    Exposures Financial Product Safety
    News headline image
    Eli Lilly's Timing of the FDA Filing of Its Next Weight-Loss Drug Is Now Official -- and Novo Nordisk Has a Problem ↗
    Via The Motley Fool
    Tickers LLY NVO
    Exposures Product Safety
    News headline image
    Artivion Q2 Earnings Call Highlights ↗
    Via MarketBeat
    Topics Earnings
    Tickers AORT
    Exposures Financial Product Safety
    News headline image
    Houston Clinic Says Published Research Does Not Establish How Long Knee Stem Cell Therapy Lasts
    Via Press Advantage
    Exposures Product Safety
    News headline image
    Kaplan Fox & Kilsheimer LLP Reminds Investors of a Securities Class Action Against Capricor Therapeutics, Inc. (NASDAQ: CAPR) and Lead Plaintiff Deadline on September 28, 2026
    Via NewMediaWire
    Topics Lawsuit
    Tickers BAC CAPR
    Exposures Financial Legal Product Safety
    News headline image
    NTRA Q2 Deep Dive: Oncology Milestones and New Product Launches Drive Growth
    Via StockStory
    Tickers NTRA
    Exposures Product Safety
    < Previous 1 2 3 4 5 6 7 8 9
    ...
    99 100 Next >
    Stock Quote API & Stock News API supplied by www.cloudquote.io
    Quotes delayed at least 20 minutes.
    By accessing this page, you agree to the Privacy Policy and Terms Of Service.
    © 2025 FinancialContent. All rights reserved.